Developer docs
API playgroundTry for free, no card

Search company profiles

Biospective

Full company profile

uuid000a893

Namestring
Biospective
Legal namestring
Biospective Inc.
Websiteurl
biospective.com
Company typeenum
Private
Founded yearint
2007
Short descriptiontext

Biospective is a preclinical neuroscience contract research organization (CRO) that provides validated rodent models and supporting CRO services (in vivo imaging, electrophysiology, biomarkers, histology, spatial biology) to pharmaceutical, biotech, and academic clients developing CNS therapeutics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMontreal, Canada
HQ citystring
Montreal
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical CRO services, neuroscience research models, rodent disease models, CNS drug development, biomarker analysis services
Industry3 codes
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
NAICS code3 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Preclinical Contract Research Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Preclinical Contract Research Services
TypeProfessional Services
Description

Fee-for-service preclinical CRO contracts providing end-to-end research services from model generation to in-life testing to quantitative tissue and fluid biomarker analysis for pharmaceutical and biotech companies developing CNS therapeutics.

biospective.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Microglia, Astrocytes, and Neurodegenerative Diseases Initiative
Description

An initiative exploring the complex relationships between neuroinflammation and neurodegeneration, aiming to enhance scientific knowledge and accelerate the development of disease-modifying therapies for ALS, Alzheimer's Disease, Tauopathies, and Parkinson's Disease.

biospective.com
Core offering1 text field

Biospective is a preclinical neuroscience contract research organization (CRO) that sells end-to-end research services for CNS drug development programs. Its core offering combines thoroughly characterized transgenic and inducible rodent models of neurodegenerative diseases (ALS, Alzheimer's, Parkinson's, Tauopathies, Multiple Sclerosis) with in-life CRO services including dosing, stereotaxic surgery, behavioral testing, electrophysiology, in vivo imaging (MRI/PET/CT), histopathology, multiplex immunofluorescence, spatial biology analysis, and fluid and cellular biomarker assays. Services are delivered on a fee-for-service project basis to pharmaceutical, biotechnology, and academic research customers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Biospective is a Preclinical Neuroscience CRO providing end-to-end contract research services from model generation to in-life testing to quantitative tissue & fluid biomarkers. Their offering includes thoroughly characterized and validated rodent models of neurological diseases (ALS, Alzheimer's Disease, Parkinson's Disease, Tauopathies, Multiple Sclerosis) along with comprehensive CRO services including Animal Services (dosing, stereotaxic surgery, tissue collection), Behavioral Testing, Electrophysiology, Fluid & Cell Biomarkers, Histology & IHC/mIF, In Vivo Imaging (MRI, PET, CT), and Spatial Biology. The company also operates a Microglia, Astrocytes, and Neurodegenerative Diseases Initiative for scientific research advancement.

Product and service12 records
1Amyotrophic Lateral Sclerosis (ALS) Rodent Models
CategoryPreclinical Disease Models
Description

TDP-43 transgenic rodent models that recapitulate ALS pathology, including the rNLS8 TDP-43ΔNLS model exhibiting cytoplasmic aggregates, motor dysfunction, neurodegeneration, neuroinflammation, and neuromuscular changes. Used by pharmaceutical and biotech sponsors developing ALS therapeutics.

2Alzheimer's Disease Rodent Models
CategoryPreclinical Disease Models
Description

Amyloid-β and tau rodent models with progressive pathologic changes in a well-defined spatiotemporal pattern, including the APP/PS1 amyloid-β transgenic mouse model and the Amyloid-Beta & Tau Co-Pathology mouse model. Used by sponsors developing Alzheimer's Disease therapeutics.

3Parkinson's Disease Rodent Models
CategoryPreclinical Disease Models
Description

α-Synuclein preformed fibril (PFF) seeding and spreading rodent models and AAV-induced α-synuclein mouse models, including the A53T variant, recapitulating different aspects of Parkinson's Disease pathology. Used by sponsors developing PD therapeutics.

4Tauopathies Rodent Models
CategoryPreclinical Disease Models
Description

Tau rodent models with progressive pathologic changes in a well-defined spatiotemporal pattern, including AAV Tau models of PSP & CBD and Tau Preformed Fibril (PFF) Seeding mouse models. Used by sponsors developing therapeutics for tauopathies.

5Multiple Sclerosis (MS) Rodent Models
CategoryPreclinical Disease Models
Description

EAE, cuprizone, and other rodent models that recapitulate autoimmune inflammation, demyelination & remyelination, and neurodegeneration aspects of human Multiple Sclerosis. Used by sponsors developing MS therapeutics.

6Animal Services
CategoryCRO Services
Description

In-life CRO services including dosing via multiple routes of administration, stereotaxic surgical procedures, and fluid & tissue collection, supporting preclinical CNS studies. Delivered to pharmaceutical, biotech, and academic customers.

7Behavioral Testing
CategoryCRO Services
Description

Specific, validated behavioral tests sensitive to response to therapy in CNS rodent models, covering motor & sensory function and sleep & cognition. Delivered to sponsors evaluating CNS therapeutics.

8Electrophysiology
CategoryCRO Services
Description

In vivo electrophysiological measures including CMAP & MUNE for motor function and CNAP for sensory function evaluation in CNS rodent models. Delivered to sponsors assessing neuromuscular and sensory endpoints.

9Fluid & Cell Biomarkers
CategoryCRO Services
Description

Measurement of clinically translational biomarkers including neurofilament light chain (NfL), Aβ40/Aβ42, Total Tau/pTau, cytokines, and chemokines in blood and cerebrospinal fluid, plus cellular immunophenotyping on brain, spinal cord, lymph nodes, and spleen tissues. Delivered to sponsors requiring translational biomarker readouts.

10Histology & IHC/mIF
CategoryCRO Services
Description

State-of-the-art histopathology facility specializing in tissues from rodent models of neurological diseases, including Immunohistochemistry (IHC) and Multiplex Immunofluorescence (mIF) for analysis of amyloid plaques, microglia, neuromuscular junction, and tau. Delivered to sponsors requiring tissue-based endpoints.

11In Vivo Imaging
CategoryCRO Services
Description

Preclinical MRI, PET, and CT scanners with advanced image processing and analysis techniques to non-invasively measure changes in brain and muscle structure and function. Delivered to sponsors requiring longitudinal non-invasive imaging endpoints.

12Spatial Biology
CategoryCRO Services
Description

Analysis of spatial relationships on multiplex immunofluorescence images using sophisticated algorithms, enabling sponsors to extract spatial tissue readouts from mIF data.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

PsychoGenics is a preclinical CRO specializing in CNS/neurological disease models with behavioral phenotyping and electrophysiology, making it the closest direct competitor to Biospective in neurodegenerative preclinical services.

TypeBroad incumbent
Description

Charles River is a global full-service preclinical CRO offering rodent models, safety assessment, and discovery services for CNS programs. It competes with Biospective on neurodegeneration models while serving many other therapeutic areas.

TypeBroad incumbent
Description

Labcorp's early development/Covance business provides preclinical CRO services including rodent efficacy/safety models relevant to Biospective's CNS offering, with much broader global scale.

TypeBroad incumbent
Description

WuXi AppTec operates one of the largest global preclinical CRO networks with rodent model services and in vivo pharmacology capabilities spanning CNS, making it a broad incumbent peer in Biospective's category.

TypeDirect peer
Description

Inotiv provides preclinical CRO services including rodent models, safety assessment, and research models with a focus on discovery and translational research, directly competing with Biospective in neurodegenerative and CNS preclinical studies.

TypeBroad incumbent
Description

Crown Bioscience provides preclinical CRO services including translational oncology and CNS-relevant models with in vivo imaging, positioned as a comparable preclinical CRO with broader therapeutic reach than Biospective.

7MD Biosciences
TypeEmerging player
Description

MD Biosciences is a preclinical CRO offering rodent models and efficacy services in inflammation, neurology, and pain, with overlapping CNS/neurodegenerative capabilities to Biospective but at smaller scale.

TypeEmerging player
Description

Sylics (part of OcellO) provides preclinical CNS/neuroscience CRO services with automated behavioral phenotyping in rodent models, a niche emerging peer to Biospective's CNS preclinical offering.

TypeEmerging player
Description

Biocytogen offers preclinical CRO services with extensive transgenic/knockout rodent model libraries and in vivo pharmacology, including CNS disease models, positioning it as an emerging alternative to specialized neuroscience CROs.

TypeOthers
Description

Clario provides clinical imaging and eCOA/eClinical solutions for CNS clinical trials and runs clinical imaging core labs, paralleling Biospective's clinical Imaging CRO arm rather than its preclinical rodent business.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biospective

Preclinical Contract Research Servicesbiospective.com

Biospective is a preclinical neuroscience contract research organization (CRO) that provides validated rodent models and supporting CRO services (in vivo imaging, electrophysiology, biomarkers, histology, spatial biology) to pharmaceutical, biotech, and academic clients developing CNS therapeutics.

Biospective firmographics

Firmographics
Name
Biospective
Legal name
Biospective Inc.
Website
https://biospective.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
51–100 employees
Short description
Biospective is a preclinical neuroscience contract research organization (CRO) that provides validated rodent models and supporting CRO services (in vivo imaging, electrophysiology, biomarkers, histology, spatial biology) to pharmaceutical, biotech, and academic clients developing CNS therapeutics.
Ownership category
akta.pro rank

Biospective industry classification

Industry
Product category
Preclinical Contract Research Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing

Keywords

  • Preclinical CRO services
  • Neuroscience research models
  • Rodent disease models
  • CNS drug development
  • Biomarker analysis services

Where Biospective is headquartered

Location

Headquarters

HQ city
Montreal
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Biospective business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Preclinical Contract Research Services: Fee-for-service preclinical CRO contracts providing end-to-end research services from model generation to in-life testing to quantitative tissue and fluid biomarker analysis for pharmaceutical and biotech companies developing CNS therapeutics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Biospective product offering

Product offering

Core offering

Biospective is a preclinical neuroscience contract research organization (CRO) that sells end-to-end research services for CNS drug development programs. Its core offering combines thoroughly characterized transgenic and inducible rodent models of neurodegenerative diseases (ALS, Alzheimer's, Parkinson's, Tauopathies, Multiple Sclerosis) with in-life CRO services including dosing, stereotaxic surgery, behavioral testing, electrophysiology, in vivo imaging (MRI/PET/CT), histopathology, multiplex immunofluorescence, spatial biology analysis, and fluid and cellular biomarker assays. Services are delivered on a fee-for-service project basis to pharmaceutical, biotechnology, and academic research customers.

Product overview

Biospective is a Preclinical Neuroscience CRO providing end-to-end contract research services from model generation to in-life testing to quantitative tissue & fluid biomarkers. Their offering includes thoroughly characterized and validated rodent models of neurological diseases (ALS, Alzheimer's Disease, Parkinson's Disease, Tauopathies, Multiple Sclerosis) along with comprehensive CRO services including Animal Services (dosing, stereotaxic surgery, tissue collection), Behavioral Testing, Electrophysiology, Fluid & Cell Biomarkers, Histology & IHC/mIF, In Vivo Imaging (MRI, PET, CT), and Spatial Biology. The company also operates a Microglia, Astrocytes, and Neurodegenerative Diseases Initiative for scientific research advancement.

Differentiator

Problem solved

Functional benefit

Brands

  • Microglia, Astrocytes, and Neurodegenerative Diseases Initiative: An initiative exploring the complex relationships between neuroinflammation and neurodegeneration, aiming to enhance scientific knowledge and accelerate the development of disease-modifying therapies for ALS, Alzheimer's Disease, Tauopathies, and Parkinson's Disease.

Products and services

  • Amyotrophic Lateral Sclerosis (ALS) Rodent Models TDP-43 transgenic rodent models that recapitulate ALS pathology, including the rNLS8 TDP-43ΔNLS model exhibiting cytoplasmic aggregates, motor dysfunction, neurodegeneration, neuroinflammation, and neuromuscular changes. Used by pharmaceutical and biotech sponsors developing ALS therapeutics.
  • Alzheimer's Disease Rodent Models Amyloid-β and tau rodent models with progressive pathologic changes in a well-defined spatiotemporal pattern, including the APP/PS1 amyloid-β transgenic mouse model and the Amyloid-Beta & Tau Co-Pathology mouse model. Used by sponsors developing Alzheimer's Disease therapeutics.
  • Parkinson's Disease Rodent Models α-Synuclein preformed fibril (PFF) seeding and spreading rodent models and AAV-induced α-synuclein mouse models, including the A53T variant, recapitulating different aspects of Parkinson's Disease pathology. Used by sponsors developing PD therapeutics.
  • Tauopathies Rodent Models Tau rodent models with progressive pathologic changes in a well-defined spatiotemporal pattern, including AAV Tau models of PSP & CBD and Tau Preformed Fibril (PFF) Seeding mouse models. Used by sponsors developing therapeutics for tauopathies.
  • Multiple Sclerosis (MS) Rodent Models EAE, cuprizone, and other rodent models that recapitulate autoimmune inflammation, demyelination & remyelination, and neurodegeneration aspects of human Multiple Sclerosis. Used by sponsors developing MS therapeutics.
  • Animal Services In-life CRO services including dosing via multiple routes of administration, stereotaxic surgical procedures, and fluid & tissue collection, supporting preclinical CNS studies. Delivered to pharmaceutical, biotech, and academic customers.
  • Behavioral Testing Specific, validated behavioral tests sensitive to response to therapy in CNS rodent models, covering motor & sensory function and sleep & cognition. Delivered to sponsors evaluating CNS therapeutics.
  • Electrophysiology In vivo electrophysiological measures including CMAP & MUNE for motor function and CNAP for sensory function evaluation in CNS rodent models. Delivered to sponsors assessing neuromuscular and sensory endpoints.
  • Fluid & Cell Biomarkers Measurement of clinically translational biomarkers including neurofilament light chain (NfL), Aβ40/Aβ42, Total Tau/pTau, cytokines, and chemokines in blood and cerebrospinal fluid, plus cellular immunophenotyping on brain, spinal cord, lymph nodes, and spleen tissues. Delivered to sponsors requiring translational biomarker readouts.
  • Histology & IHC/mIF State-of-the-art histopathology facility specializing in tissues from rodent models of neurological diseases, including Immunohistochemistry (IHC) and Multiplex Immunofluorescence (mIF) for analysis of amyloid plaques, microglia, neuromuscular junction, and tau. Delivered to sponsors requiring tissue-based endpoints.
  • In Vivo Imaging Preclinical MRI, PET, and CT scanners with advanced image processing and analysis techniques to non-invasively measure changes in brain and muscle structure and function. Delivered to sponsors requiring longitudinal non-invasive imaging endpoints.
  • Spatial Biology Analysis of spatial relationships on multiplex immunofluorescence images using sophisticated algorithms, enabling sponsors to extract spatial tissue readouts from mIF data.

Companies that use Biospective

Customer profile

Segments2 records

Ideal customer profiles2 records

Biospective technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Biospective partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Biospective competitors and assessment

Company assessment

Direct peers

  • PsychoGenics: PsychoGenics is a preclinical CRO specializing in CNS/neurological disease models with behavioral phenotyping and electrophysiology, making it the closest direct competitor to Biospective in neurodegenerative preclinical services.
  • Inotiv: Inotiv provides preclinical CRO services including rodent models, safety assessment, and research models with a focus on discovery and translational research, directly competing with Biospective in neurodegenerative and CNS preclinical studies.

Broad incumbents

  • Charles River Laboratories: Charles River is a global full-service preclinical CRO offering rodent models, safety assessment, and discovery services for CNS programs. It competes with Biospective on neurodegeneration models while serving many other therapeutic areas.
  • Labcorp (Covance Early Development): Labcorp's early development/Covance business provides preclinical CRO services including rodent efficacy/safety models relevant to Biospective's CNS offering, with much broader global scale.
  • WuXi AppTec: WuXi AppTec operates one of the largest global preclinical CRO networks with rodent model services and in vivo pharmacology capabilities spanning CNS, making it a broad incumbent peer in Biospective's category.
  • Crown Bioscience (JSR Life Sciences): Crown Bioscience provides preclinical CRO services including translational oncology and CNS-relevant models with in vivo imaging, positioned as a comparable preclinical CRO with broader therapeutic reach than Biospective.

Emerging players

  • MD Biosciences: MD Biosciences is a preclinical CRO offering rodent models and efficacy services in inflammation, neurology, and pain, with overlapping CNS/neurodegenerative capabilities to Biospective but at smaller scale.
  • Sylics (an OcellO company): Sylics (part of OcellO) provides preclinical CNS/neuroscience CRO services with automated behavioral phenotyping in rodent models, a niche emerging peer to Biospective's CNS preclinical offering.
  • Biocytogen: Biocytogen offers preclinical CRO services with extensive transgenic/knockout rodent model libraries and in vivo pharmacology, including CNS disease models, positioning it as an emerging alternative to specialized neuroscience CROs.

Others

  • Clario (formerly Bioclinica/ERT): Clario provides clinical imaging and eCOA/eClinical solutions for CNS clinical trials and runs clinical imaging core labs, paralleling Biospective's clinical Imaging CRO arm rather than its preclinical rodent business.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Biospective social profiles

Digital presence

Biospective financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biospective leadership team

Management profile

Number of profiles

Biospective funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biospective M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biospective

What does Biospective do?

Biospective is a preclinical neuroscience contract research organization (CRO) that sells end-to-end research services for CNS drug development programs. Its core offering combines thoroughly characterized transgenic and inducible rodent models of neurodegenerative diseases (ALS, Alzheimer's, Parkinson's, Tauopathies, Multiple Sclerosis) with in-life CRO services including dosing, stereotaxic surgery, behavioral testing, electrophysiology, in vivo imaging (MRI/PET/CT), histopathology, multiplex immunofluorescence, spatial biology analysis, and fluid and cellular biomarker assays. Services are delivered on a fee-for-service project basis to pharmaceutical, biotechnology, and academic research customers.

Is Biospective a public or private company?

Biospective is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Biospective founded?

Biospective was founded in 2007. It employs 51 to 100 people.

Where is Biospective based?

Biospective is headquartered in Montreal, Canada, in the North America region.

How does Biospective make money?

One revenue line is on record: preclinical Contract Research Services.

Who are Biospective's main competitors?

Direct peers on record are PsychoGenics and Inotiv. Broad incumbents are Charles River Laboratories, Labcorp (Covance Early Development), WuXi AppTec and Crown Bioscience (JSR Life Sciences). Emerging players are MD Biosciences, Sylics (an OcellO company) and Biocytogen. Clario (formerly Bioclinica/ERT) is listed as an others.

Does Biospective have an API?

No public API is recorded for Biospective.

What industry is Biospective in?

Biospective's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales